Tag: research

Research Shows Oral and Topical Agents Hold Promise in Preventing UV-Induced Skin Cancer

Source: American Academy of Dermatology
Related MedlinePlus Page: Skin Cancer (Source: MedlinePlus Health News)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

Source: MedWorm: Oral Cancer

  • Share/Bookmark

Tags: , , , , , , , , , ,

FAMRI-funded Research Helps Harness Cancer-killing Viruses

The Flight Attendant Medical Research Institute (FAMRI; www.famri.org), a not-for-profit organization, sponsors scientific and medical research to combat diseases caused by exposure to tobacco smoke.

Since 2001, FAMRI has relied on Scientific Peer Advisory and Review Services (AIBS SPARS) to manage large- and small-conference peer review meetings that have marshaled the wide-ranging expertise of hundreds of reviewers and funded nearly 500 projects addressing the prevention, early detection, treatment, and cure of the diseases and medical conditions caused by tobacco smoke.

Diffused among healthy cells, especially at early stages, and growing out of control, cancer cells are difficult to target precisely. As a result, traditional anticancer therapies are blunt instruments: chemotherapy ca…

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

Source: MedWorm: Oral Cancer

  • Share/Bookmark

Tags: , , , , ,

MethylGene Presents Preclinical Data for MGCD265 (A Multi-Targeted Met Kinase Inhibitor) at the American Association for Cancer Research (AACR) Annual Meeting

MGCD265 is an oral multi-targeted receptor tyrosine kinase inhibitor currently in multiple clinical trials. MGCD265 targets Met and blocks Met activities which contribute to cancer development and progression such as cell proliferation, motility, angiogenesis and tumor cell survival.04/21/2010 (Source: Kidney Cancer Association) Source: MedWorm: Oral Cancer

  • Share/Bookmark

Tags: , , , , , , , , , , , , , ,

Pharmacyclics Announces Multiple Presentations At The American Association For Cancer Research Annual Meeting

Pharmacyclics, Inc. (Nasdaq: PCYC) announced multiple presentations covering its Btk and HDAC programs at the American Association for Cancer Research (AACR) 2010 Annual Meeting being held April 17-21 in Washington, DC. The oral presentation describes efficacy of the company’s first-in-human Btk inhibitor PCI-32765 in a mouse model of pancreatic cancer (Soucek et al). Two other presentations describe the discovery of drug synergy with the company’s HDAC inhibitor, PCI-24781 and the drug bortezomib in neuroblastoma (Currier et al), or with inhibitors of LSD1 in glioblastoma (Singh et al)… (Source: Health News from Medical News Today)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of authoritative health and news sources.

Source: MedWorm: Oral Cancer

  • Share/Bookmark

Tags: , , , , , , , , ,

New Research In Women’s Health To Be Presented In San Francisco

Obstetrician-gynecologists from around the country and internationally will convene in San Francisco to present new research at The American College of Obstetricians and Gynecologists 58th Annual Clinical Meeting. The latest unpublished research on a wide range of women’s health issues, including cesarean delivery, contraception, experimental drugs, infertility, infectious diseases, gynecologic cancer, menopause, obstetric procedures, and urogynecology, will be released in both oral and poster abstract format at the Moscone Center, Monday, May 17, and Tuesday, May 18… (Source: Health News from Medical News Today)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of authoritative health and news sources.

Source: MedWorm: Oral Cancer

  • Share/Bookmark

Tags: , , , ,

Max Planck Scientists Develop A Fingerprint For Genes: New Strategy To Play Major Role In Research On Human Diseases

Cells may not have a mouth, but they still need to ingest substances from the external environment. If this process – known as endocytosis – is affected, it can lead to infectious diseases or cardio-vascular diseases, cancer, Huntington’s and diabetes… (Source: Infectious Diseases / Bacteria / Viruses News From Medical News Today)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of authoritative health and news sources.

Source: MedWorm: Oral Cancer

  • Share/Bookmark

Tags: , , , , , , , , , , ,

Progenics Presents Novel Multiplex PI3-Kinase Inhibitors At American Association For Cancer Research Conference On Protein Translation And Cancer

Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced the presentation of preclinical data on a series of novel compounds that simultaneously blocked two critical pathways involved in the growth and survival of cancer cells. The compounds were identified as part of the Company’s ongoing oncology drug discovery efforts. The data are being presented in both oral and poster sessions at the American Association for Cancer Research (AACR) conference on Protein Translation and Cancer in Coronado, CA… (Source: Health News from Medical News Today) Source: MedWorm: Oral Cancer

  • Share/Bookmark

Tags: , , , , , , , , , , , ,

Wakefield was dishonest and irresponsible over MMR research, says GMC

(Source: BMJ Online First)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of authoritative health and news sources.

Source: MedWorm: Oral Cancer

  • Share/Bookmark

Tags: , , , ,

Powered by WordPress

Blossom Theme by RoseCityGardens.com